Back to Treatments

Treatment

Zoster Vaccine, Recombinant, Adjuvanted (Shingrix)

1
Conditions
9
Trials
40K
Participants
85%
Average Safety

Condition Evidence

Varicella and herpes zoster

9 trials · 40K participants

95% effectiveness · 85% safety
Zoster Vaccine, Recombinant, Adjuvanted (Shingrix) | DFDA